Sunday, September 20, 2026

Moderna Stock Is 17.73% Up So Far On Friday

ViaNews Editorial Team

November 27, 2020

Moderna Stock Is 17.73% Up So Far On Friday

Shares of Moderna jumped by a staggering 17.73% to $128.54 at 11:07 EST on Friday, following yesterday's upward trend. The Nasdaq Stock Market is jumping 1.07% to $12,224.10, after three successive sessions in a row of gains, on what so far seems, an all-around positive trend trading session today.

Moderna's last close was $109.18, 3.71% under its 52-week high of $123.94.

Moderna's sales growth is 1425.2% for the present quarter and 9666.5% for the next. The company's growth estimates for the present quarter is a negative 48.6% and positive 437.1% for the next.

Year-on-year quarterly revenue growth grew by 826.4%, now sitting on 246.7M for the twelve trailing months.

Moderna's stock is valued at $128.54 at 11:07 EST, higher than its 52-week high of $123.94.

Moderna's worth is way above its 50-day moving average of $79.01 and way higher than its 200-day moving average of $70.45.

According to Bloomberg Quint on Mon Nov 23, "Moderna Chief Sells More Shares Ahead of Urgent Vaccine Filing."

According to Bloomberg Quint on Wed Nov 25, "Moderna Soars to Record Ahead of Final Covid Vaccine Analysis."

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Boom Hits a Fork: Slowdown Calls Clash with Capex Confidence as Markets Get Nervous
Dario Amodei's repeated calls for a global slowdown in frontier AI development, echoed by Microsoft's new humanist AI code of conduct and FTC antitrust caution, are being publicly rejected by Nvidia and Meta leadership even as hyperscaler spending draws fresh skeptical scrutiny (Wachter's analysis, Burry-style overbuilding worries) and weak guidance from Adobe and a post-slowdown-comment selloff in GE Vernova signal investor jitters. Meanwhile wealth and security effects of the AI race keep compounding — Zhang Yiming's fortune surging on AI-driven ByteDance value, a Chinese hacking firm weaponizing AI against stolen government secrets, and low-quality AI-generated products (an AI sitcom, a spam-flooding agent platform) fueling backlash even as adoption races ahead.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,982
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,982 facts checked against source5,299 source documents archived
Query this data → isubstrate.com